Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED
02 1Neuland Laboratories Limited
03 1Apothecon Pharmaceuticals Pvt Ltd
04 1Archimica S.p.A.
05 1Aurobindo Pharma Limited
06 1Cadila Pharmaceuticals Limited
07 1Chemeca Drugs Private Limited
08 1Glenmark Life Sciences Limited
09 1HETERO LABS LIMITED
10 1Hetero Labs Limited
11 1Honour Lab Limited
12 1SOLARA ACTIVE PHARMA SCIENCES LIMITED
13 1Spectrum Laboratory Products, Inc.
14 2Sumitomo Chemical Company, Limited
15 1Wanbury Limited
01 2HYDRALAZINE HYDROCHLORIDE
02 14Hydralazine Hydrochloride
01 12India
02 1Italy
03 2Japan
04 1U.S.A
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-102
Start Marketing Date : 2020-07-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-1004
Start Marketing Date : 2017-12-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55512-0010
Start Marketing Date : 2009-11-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-148
Start Marketing Date : 2024-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65691-0088
Start Marketing Date : 2020-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-957
Start Marketing Date : 2021-02-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-3544
Start Marketing Date : 2001-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68259-1313
Start Marketing Date : 2014-02-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68259-1307
Start Marketing Date : 2009-06-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62350-0080
Start Marketing Date : 2018-12-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Hyperex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hyperex, including repackagers and relabelers. The FDA regulates Hyperex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hyperex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hyperex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hyperex supplier is an individual or a company that provides Hyperex active pharmaceutical ingredient (API) or Hyperex finished formulations upon request. The Hyperex suppliers may include Hyperex API manufacturers, exporters, distributors and traders.
click here to find a list of Hyperex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hyperex as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hyperex API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hyperex as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hyperex and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hyperex NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hyperex suppliers with NDC on PharmaCompass.
We have 14 companies offering Hyperex
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
